Series C · Healthtech
CereVasc: Series C
Develops minimally invasive eShunt System to treat communicating hydrocephalus and other neurological diseases
Funding history
Series C · This round$85M
Loading rounds…
Develops minimally invasive eShunt System to treat communicating hydrocephalus and other neurological diseases